From: Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
 | HR | 95% CI | P |
---|---|---|---|
Univariate analysis | |||
 Age, per year | 1.017 | 0.992 – 1.042 | 0.188 |
 Gender, Male = 1 | 3.572 | 1.104 – 11.553 | 0.034 |
 Anti-HCV, positive = 1 | 1.208 | 0.618 – 2.360 | 0.581 |
 HBsAg, positive = 1 | 0.866 | 0.456 – 1.643 | 0.660 |
 Liver cirrhosis, yes = 1 | 1.125 | 0.610 – 2.074 | 0.707 |
 Microvascular invasion, yes = 1 | 2.742 | 1.491 – 5.041 | 0.001 |
 Macrovascular invasion, yes = 1 | 4.081 | 1.999 – 8.332 | < 0.001 |
 Histology grade, per grade | 1.473 | 0.951 – 2.281 | 0.083 |
 Capsule, yes = 1 | 0.980 | 0.511- 1.880 | 0.952 |
 Tumor number, per number | 1.308 | 1.007 – 1.700 | 0.044 |
 Ascites yes = 1 | 1.048 | 0.253 – 4.348 | 0.948 |
 Alcoholism yes = 1 | 1.043 | 0.535 – 2.033 | 0.9903 |
 Largest tumor size, per cm | 1.009 | 0.973 – 1.047 | 0.613 |
 AFP, per ng/mL | 1.037 | 1.003 – 1.073 | 0.035 |
 Albumin, per g/L | 0.740 | 0.442 – 1.239 | 0.252 |
 Bilirubin, per mg/dL | 0.954 | 0.713 – 1.275 | 0.748 |
 PT, per sec | 1.084 | 0.903 – 1.302 | 0.385 |
 Creatinine, per mg/dL | 0.891 | 0.567 – 1.399 | 0.615 |
 AST, per U/L | 1.001 | 0.998 – 1.004 | 0.534 |
 ALT, per U/L | 1.000 | 0.996 – 1.003 | 0.787 |
Multivariate analysis | |||
 Gender, Male = 1 | 3.413 | 1.042 – 11.183 | 0.043 |
 Microvascular invasion, yes = 1 | 2.687 | 1.426 – 5.060 | 0.002 |
 Macrovascular invasion, yes = 1 | 4.209 | 1.867 – 9.490 | 0.001 |
 Tumor number, per number | 1.004 | 0.749 – 1.347 | 0.977 |
 AFP, per ng/mL | 1.052 | 1.015 – 1.089 | 0.005 |